Nora Dunne is the publications editor for the medical school’s Office of Communications. She edits Northwestern Medicine Magazine and writes news stories about research ranging from basic and translational sciences to public health. She has a bachelor’s degree in journalism from Boston University and is currently earning a master’s degree in integrated marketing communications at Northwestern. email@example.com
New Northwestern Medicine research has shown that reprogrammed stem cells can be used to identify patients with cancer who are likely to experience a dangerous side effect of a common chemotherapy drug.